ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0020

Feasibility and Accuracy of Left Ventricular Ejection Fraction Assessment by Nephrology Professionals Using Artificial Intelligence

Session Information

Category: Artificial Intelligence, Digital Health, and Data Science

  • 300 Artificial Intelligence, Digital Health, and Data Science

Authors

  • Filardo-Zuniga, Marimar, Tecnologico de Monterrey - Campus Ciudad de Mexico, Mexico City, CDMX, Mexico
  • Nieves Hernández, Luz Atenas, Tecnologico de Monterrey - Campus Ciudad de Mexico, Mexico City, CDMX, Mexico
  • Hernandez-Garcia, Leslie Nahomi, Tecnologico de Monterrey - Campus Ciudad de Mexico, Mexico City, CDMX, Mexico
  • Arvizu Hernández, Mauricio, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
Background

Evaluate the feasibility and accuracy of nephrologists measuring the left ventricular ejection fraction (LVEF) in patients with chronic kidney disease (CKD) and heart failure using portable ultrasound with artificial intelligence compared to formal echocardiography by cardiologists.

Methods

A retrospective descriptive study was conducted in the cardionephrology clinic of a tertiary hospital in Mexico City from April 1 to July 10, 2024. LVEF measurements by nephrologists using the EchoNous KOSMOS portable ultrasound with artificial intelligence were compared to formal echocardiography performed by cardiologist echocardiographers.

Results

Twenty-seven patients with both nephrologist-performed and prior formal LVEF measurements were included. Of these, 55.5% were male, with a mean age of 43.2±16.1 years. Overall, 92.5% were on renal replacement therapy: 62.9% on hemodialysis (mean 4 years), 29.6% on peritoneal dialysis (mean 3 years), one in pre-dialysis, and one post-transplant. The correlation between LVEF measurements by nephrologists and cardiologists was strong (r=0.825), with good agreement on Bland-Altman analysis. Mean LVEF was 49.5±11.6% (nephrologists) and 50.5±13.3% (echocardiography). LVEF classification was consistent: 28.5% reduced, 25.9% mildly reduced, and 51.8% preserved.

Conclusion

Nephrologists can accurately calculate LVEF using artificial intelligence in patients with CKD and heart failure, yielding comparable results to cardiologists. This demonstrates the feasibility of integrating nephrologists into the cardiac assessment of these patients.

Digital Object Identifier (DOI)